prohibitin-targeting peptide 1 CKGGRAKDC (SEQ ID NO: 1) targeting peptide associates with prohibitin - Adipotide FTPPpeptide Adipotide, formerly known as Prohibitin-TP01 Prohibitin-Targeting Peptide 1: A Novel Approach to Obesity and Cancer Treatment

Adipotidepeptideresults Prohibitin-targeting peptide 1 (Prohibitin-TP01), also known as adipotide, represents a significant advancement in therapeutic strategies, particularly for conditions like obesity and certain cancers."Groundbreaking study on prohibitin peptides for obesity" This chimeric, 25-mer peptide is engineered to precisely target prohibitin, a protein found to be crucial in various cellular functions, including adipocyte biology and cancer cell proliferation. Its innovative mechanism of action focuses on disrupting the function of specific tissues, offering a more localized and potentially less toxic therapeutic approach.A Peptidomimetic Targeting White Fat Causes Weight Loss ...

At its core, Prohibitin-TP01 operates by selectively binding to prohibitin. This protein is notably expressed on the surface of adipose cells, making it a prime target for weight loss interventions. By targeting specific blood vessels supplying adipose tissue with blood, adipotide causes these vessels to shrink, thereby reducing the blood supply to fat cells. This mechanism effectively leads to the destruction of white fat, the type of fat commonly associated with metabolic issues and obesity, particularly in men.Prohibitin targeting peptide 1 - Drug Targets, Indications, ... Research has demonstrated that peptides like Prohibitin-TP01 can induce apoptosis in adipocytes, leading to significant reduction of body weight in preclinical models, such as the high-fat diet-induced obesity mouse model.

Beyond its anti-obesity applications, the targeting capabilities of Prohibitin-TP01 have also been explored in oncology. Prohibitin is implicated in the proliferation of certain cancer cells, and by targeting prohibitin, Adipotide has shown potential as an antineoplastic agent. Studies have investigated its use in conjunction with chemotherapy or as a standalone treatment, aiming to induce prohibitin-TP01 mediated tumor cell death作者：J Hong·2022·被引用次数：35—Prohibitinbindingpeptide(PBP), an oligopeptidetargeting prohibitinrich in adipose tissue, is conjugated on the surface of Hemin- or CoPP- .... For instance, the CKGGRAKDC peptide, known to associate with prohibitin, has been identified as a key component in such therapeutic strategiesDefinition of prohibitin-targeting peptide 1 - NCI Drug .... This CKGGRAKDC (SEQ ID NO: 1) targeting peptide associates with prohibitin due to prohibitin's role as a multifunctional membrane-associated protein.

The development of Prohibitin-targeting peptide 1 has involved extensive research and clinical trials. A first-in-man, Phase I evaluation of Prohibitin-TP01 investigated its tolerability and safety profile in patients with advanced conditions, including metastatic prostate cancer and obesityTargeted delivery of CRISPR interference system against .... The primary goal of such trials is to determine the highest tolerable dose of PROHIBITIN-TP01 that can be safely administered. While the precise Adipotide peptide dosage can vary depending on the study and patient population, the focus remains on optimizing efficacy while minimizing adverse effects.Definition of prohibitin-targeting peptide 1 - NCI Drug ...

Various iterations and related compounds have emerged from this research. HKPao (Hunter-killer peptide ao) is another biologically active peptide that shares similar anti-obesity and anti-tumor apoptotic activities.Fatty Liver/Adipose Tissue Dual‐Targeting Nanoparticles ... Furthermore, the concept of vascular-targeted nanotherapy for obesity has utilized prohibitin-targeted nanoparticles (PTNP), where a peptide ligand is conjugated to deliver therapeutic agents directly to adipose tissue. These nanoparticles, modified with a prohibitin-homing peptide like KGGRAKDC, function as a targeting motif.

The scientific community continues to explore the full potential of these targeting prohibitin peptides. Research efforts are focused on refining the delivery mechanisms, understanding the Adipotide peptide benefits, and characterizing potential Adipotide peptide side effects. Studies involving mixed-chirality prohibitin peptides and fatty liver/adipose tissue dual-targeting nanoparticles further illustrate the ongoing innovation in this field. The ability of Adipotide to selectively destroy white fat and its potential anti-cancer properties underscore its significance as a promising therapeutic candidate. As research progresses, the precise Adipotide peptide how to use and optimal Adipotide peptide results will become clearer, paving the way for its broader clinical application.Definition of prohibitin-targeting peptide 1 - NCI Drug ...